Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-081982
Filing Date
2021-06-16
Accepted
2021-06-16 16:01:50
Documents
3
Effectiveness Date
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2119432d1_s8.htm S-8 70187
2 EXHIBIT 5.1 tm2119432d1_ex5-1.htm EX-5.1 5948
3 EXHIBIT 23.1 tm2119432d1_ex23-1.htm EX-23.1 2192
  Complete submission text file 0001104659-21-081982.txt   79547
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257137 | Film No.: 211021441
SIC: 2835 In Vitro & In Vivo Diagnostic Substances